Chung, Chiwook
Park, Suk Young
Huh, Jin-Young
Kim, Na Hyun
Shon, ChangHo
Oh, Eun Yi
Park, Young-Jun
Lee, Seon-Jin
Kim, Hwan-Cheol
Lee, Sei Won
Funding for this research was provided by:
Korea Research Institute of Bioscience and Biotechnology (Research Initiative Program (YJP))
Korea Centers for Disease Control and Prevention (No. 2019ER671100 and 01, and 2021ER120900)
Article History
Received: 22 October 2022
Accepted: 4 April 2024
First Online: 24 April 2024
Declarations
:
: All animal care and experimental procedures were approved by Institutional Animal Care and Use Committee of Asan Medical Center (approval number 2020-12-342). The previous clinical study was individually approved by the Institutional Review Boards as follows: Asan Medical Center (2019 − 0479), Gangneung Asan Hospital (2019-06-049), Ulsan University Hospital (2019-07-049), and Gachon University Gil Medical Center (GBirb2019-290). All participants were given detailed information about the study and provided written informed consent. The study is registered at ClinicalTrials.gov (Registration No. NCT04020237). The present study adhered to the Declaration of Helsinki and the ARRIVE guidelines, and all procedures were carried out in accordance with the relevant guidelines.
: Not applicable.
: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.